MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in MiNK Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q4 2025
- Shares held
- 126.8K
- +41.3K (+48.2%) vs. Q4 2025
- Total value
- $1.34M
- +$381.7K (+40.0%) vs. Q4 2025
- New holders
- 5
- 2 more added
- Sold out
- 6
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 59,364 | $625.1K | 0.00% | +59,364 | New |
| Geode Capital Management, LLC | 17,345 | $182.7K | 0.00% | +3,098+21.7% | Added |
| Longbow Finance SA | 16,667 | $175.5K | 0.03% | 00.0% | Unchanged |
| UBS Group AG | 15,202 | $160.1K | 0.00% | +5,654+59.2% | Added |
| Vanguard Fiduciary Trust Co | 8,287 | $87.3K | 0.00% | +8,287 | New |
| BlackRock, Inc. | 6,203 | $65.3K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,000 | $21.1K | 0.00% | +2,000 | New |
| Paladin Partners, LLC | 1,000 | $10.5K | 0.01% | 00.0% | Unchanged |
| Annis Gardner Whiting Capital Advisors, LLC | 200 | $2.11K | 0.00% | +200 | New |
| Tower Research Capital LLC (TRC) | 156 | $1.64K | 0.00% | −139−47.1% | Reduced |
| Morgan Stanley | 104 | $1.09K | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 119 | $1.00K | 0.00% | −12−9.2% | Reduced |
| Citigroup Inc | 91 | $958 | 0.00% | −246−73.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 18 | $190 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 16 | $168 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 16 | $168 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 14 | $148 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 10 | $105 | 0.00% | +10 | New |
| JPMorgan Chase & Co | 9 | $95 | 0.00% | 00.0% | Unchanged |
| Pinnacle Wealth Planning Services, Inc. | 5 | $53 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 4 | $42 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $11 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1 | $10 | 0.00% | −116−99.1% | Reduced |
| DRW Securities, LLC | 0 | $0 | 0.00% | −25,677−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −568−100.0% | Sold out |
| Horizon Financial Services, LLC | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |